4//SEC Filing
Carter Denise P. 4
Accession 0001104659-24-132190
CIK 0001671502other
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 5:17 PM ET
Size
10.0 KB
Accession
0001104659-24-132190
Insider Transaction Report
Form 4
Carter Denise P.
DirectorChief Operating Officer
Transactions
- Purchase
Series F Warrants (right to buy)
2024-12-23+555,556→ 555,556 totalExercise: $0.45From: 2024-12-23Exp: 2026-12-23→ ADS (555,556 underlying) - Purchase
Series G Warrants (right to buy)
2024-12-23+555,556→ 555,556 totalExercise: $0.45From: 2024-12-23Exp: 2029-12-24→ ADS (555,556 underlying) - Purchase
Ordinary Shares
2024-12-23$0.45/sh+555,556$250,000→ 602,648 total
Footnotes (3)
- [F1]Reported securities are represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
- [F2]Each ADS purchased together with a Series F Warrant to purchase one ADS and a Series G Warrant to purchase one ADS in the Issuer's public offering which closed on December 23, 2024, at a combined public offering price of $0.45. The Series F Warrants and the Series G Warrants are collectively referred to as the "Warrants."
- [F3]The Warrants were exercisable immediately, subject to a beneficial ownership cap.
Documents
Issuer
Quoin Pharmaceuticals, Ltd.
CIK 0001671502
Entity typeother
Related Parties
1- filerCIK 0001958621
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 5:17 PM ET
- Size
- 10.0 KB